Lupus Trial, Recruiting NCT05443516 Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain Condition: Lupus
Back to Lupus

Lupus Trial, Recruiting

NCT05443516
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Systemic Lupus Erythematosus (SLE) according to standard international classification guidelines.
  • People who are 18 years of age or older.
  • People who have a new or returning case of lupus nephritis (lupus-related kidney disease) that has been confirmed through a kidney biopsy showing a specific type of kidney involvement.

Who may not be able to join:

  • People who have a kidney condition related to antiphospholipid syndrome (a blood-clotting disorder that can affect the kidneys).
  • People who are pregnant at the time of joining the trial (becoming pregnant during the trial does not automatically lead to removal from the trial).
  • People whose treating doctor anticipates they may have difficulty following the required treatment plan.
  • People who have other medical conditions that could interfere with measuring the trial's results (confirm with trial site).
  • People who are unable to read or sign the consent form.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Frédéric Houssiau, Pr, Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Phone: +32 02 764 53 90

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Registry
ClinicalTrials.gov
Start date
16 June 2014
Est. completion
31 December 2022

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Biomarker analysis of lupus nephritis activity - whole blood cell populations; Biomarker analysis of lupus nephritis activity - blood cytokines; Biomarker analysis of lupus nephritis activity - urine cytokines

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov